An Amgen researcher in lab that developed the new Lumakras cancer treatment (courtesy photo) In 2018, Amgen got its first green light to administer a new drug called sotorasib to people in clinical trials. Just three years later, that drug, now known as Lumakras, has been approved as a cancer treatment by the U.S. Food…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
